MedTrace Logo

Use of Continence Care Protocol in UK Nursing Homes.

NCT06100458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2023-10-25

No results posted yet for this study

Summary

This is a retrospective cohort study. In the investigation the clinical use of the Skin and leakage protocol (SLEP) is to be investigated. The SLEP is a generic digital diary form filled out to give information about the current status of continence care among care home residents. The SLEP tracks the number of leakage occurrences and daily skin health over a period of time with the purpose of assisting care staff in making decisions regarding continence care. The SLEP has been introduced at several United kingdom National Health Service care homes and with this investigation the investigators want to retrospectively analyse the data to determine the clinical usefulness of the form.

The primary objective of the study is to describe any changes in product leakage rate at the baseline and follow up time period.

Conditions

Interventions

OTHER

Skin and leakage protocol

The skin and leakage protocol have been developed by the sponsor with the aim to offer a tool that can aid care providers in identifying problems in continence care and follow up the effect of any care interventions to remedy these problems. The protocol is a digital diary tool that tracks both the instances of urine leaking out of an absorbing incontinence product onto clothes and bedsheets, and any apparent skin changes in the area covered by the product. The protocol is in clinical use at the care homes were the subjects are residing.

Sponsors & Collaborators

  • Lincolnshire Community Health Services NHS Trust

    collaborator OTHER

  • Essity Hygiene and Health AB

    lead INDUSTRY

Principal Investigators

  • Debbie Jeffrey · Lincolnshire Community Health Services National Health Services Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-02-02
Completion
2023-02-02

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06100458 on ClinicalTrials.gov